3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD
Year: 2021
Type: editorial
Abstract: 3TR, the largest IMI consortium ever in immune diseases, brings clinical researchers and scientists from several disease areas together, in an endeavour to increase the clinical impact of targeted immune-mediated therapies, including asthma and COPDhttps://bit.ly/3kPq0xI
Source: European Respiratory Journal
Authors: Celeste Porsbjerg, Anke H. Maitland-van der Zee, Guy Brusselle, Giorgio Walter Canonica, Alvar Agusti, Rosa Faner, Claus F. Vogelmeier, Martijn Nawijn, Maarten van den Berge, Franca Rusconi, Charles Pilette, Valeria Ramiconi, Courtney Coleman, Rekha Chaudhuri, Kian Fan Chung, Jadwiga Wedzicha, Sejla Saglani, Marc P. Van der Schee, Liam Heaney, Arnaud Bourdin, Graham Roberts, Ratko Djukanovic, Piotr Kuna, Maciej Kupczyk, Judith Axmann, Heribert Staudinger, Graham W. Clarke, Sven Erik Dahlen, Chris Brightling
Institutions: Bispebjerg Hospital, Amsterdam University Medical Centers, University of Amsterdam, Ghent University Hospital, Humanitas University, IRCCS Humanitas Research Hospital, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Philipps University of Marburg, German Center for Lung Research, University Medical Center Groningen, University of Groningen, Meyer Children's Hospital, Cliniques Universitaires Saint-Luc, UCLouvain, European Federation of Allergy and Airways Diseases Patients Associations, European Lung Foundation, University of Glasgow, Imperial College London, Royal Brompton Hospital, Owlstone Medical (United Kingdom), Queen's University Belfast, Centre National de la Recherche Scientifique, Inserm, Physiologie et Médecine Expérimentale du Coeur et des Muscles, Centre Hospitalier Universitaire de Montpellier, University Hospital Southampton NHS Foundation Trust, NIHR Southampton Biomedical Research Centre, St Mary's Hospital, David Hide Asthma and Allergy Research Centre, St. Mary's Hospital, University of Southampton, Medical University of Lodz, F. Hoffmann-La Roche AG, Sanofi (United States), AstraZeneca (Sweden), Karolinska University Hospital, Karolinska Institutet, University of Leicester
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3205408749